Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | -.--% | -.--% | -.--% |
2019 | Roivant Sciences GmbH cancelled the acquisition of substantially all of the assets from PhaseRx, Inc. | CI |
2018 | PhaseRx, Inc. Bankruptcy Case Dismissed | CI |
- Stock Market
- Equities
- PZRXQ Stock
- News PhaseRx, Inc.
- Analyst Reco.